**Specifications Table**TableSubject areaPlant Physiology and BiochemistryMore specific subject areaGlutathione metabolismType of dataMS data and annotations, spectrophotometric and chromatographic dataHow data was acquiredi-TRAQ labelled peptides were analysed using mass spectrometry (LTQ Orbitrap, Thermo Scientific)Data formatAnalysed output dataExperimental factorsApoplastic fluids (or ECWF, Extra-Cellular Washing Fluid) were obtained by the infiltration/centrifugation methodExperimental featuresDepending on the purpose of analysis, different infiltration buffers were used for antioxidant measurements or proteome composition analysis.Data source locationNOT APPLICABLEData accessibilityProteomic data are stored and available in a public repository (PRIDE database, PXD001807, url: 〈<http://proteomecentral.proteomexchange.org/dataset/PXD001807>〉)

**Value of the data**•Apoplastic proteomes from *A. thaliana* wt and ggt1- knockout mutants are compared for functional characterization of the cell-wall bound gamma-glutamyl transferase/transpeptidase GGT1 enzyme.•Effects of UV-B radiation on the extracellular protein composition are also reported.•Quantitative proteomics was performed by iTRAQ labelling.•Results point to a role for apoplastic GGT1 in redox sensing/signaling.

1. Experimental design {#s0005}
======================

A major aim of this analysis was to obtain information on the significance of the enzyme gamma-glutamyl transferase (GGT) in the response to oxidative conditions. Since the apoplastic isoform GGT1 is extracellular and cell-wall bound, we hypothesised that disrupting this enzyme׳s activity would result in altered redox conditions in the apoplast, that may affect the overall response to oxidative stress conditions starting from the apoplast. To this regard, UV-B radiation is known to induce oxidative damage to plasma membranes and originate ROS in the apoplast.

Therefore, we used a *ggt1* mutant line that had been previously characterized [@bib3][@bib4], and imposed a UV-B treatment. In this way, we generated four experimental conditions: 1) untreated, wildtype; 2) untreated, *ggt1* mutant; 3) UV-B treated, wildtype; and 4) UV-B treated, *ggt1* mutant.

Finally, we obtained the extracellular washing fluid (ECWF) with the aim to gain the following information: i) the effect of UV-B treatment on each genotype; ii) differential apoplastic protein composition in *ggt1 vs* . wildtype; iii) possible differences in the behavior of the *ggt1* mutant and the wildtype under UV-B.

2. Materials and methods {#s0010}
========================

2.1. Plant materials and growth conditions {#s0015}
------------------------------------------

Seeds of *Arabidopsis thaliana* wildtype and a *ggt1* knockout mutant line, both Columbia ecotype (Col-0), were obtained from the Nottingham A. thaliana Stock Centre (〈<http://nasc.nott.ac.uk>〉; polymorphism SALK_080363) [@bib5]. The UV-B treatment was applied for 8 h at the beginning of the light period, to plants at the stage of fully expanded rosette. The growth chamber settings were: 12/12 h light/dark cycle, 21/21 °C temperature, 300 µmol m^−2^ s^−1^ photosynthetically active radiation, and 60% relative humidity. The radiation was provided by two Philips TL40W/12 lamps with an intensity of 8.3 kJ m^−2^ d^−1^ (UVBBE, biologically effective UV-B), measured on the level of the plants.

2.2. Apoplastic fluid extraction {#s0020}
--------------------------------

Extracellular washing fluids (ECWF) were extracted by vacuum infiltration ([Fig. 1](#f0005){ref-type="fig"}). About 1 g of mature fresh leaves were cut from 4 to 5 Arabidopsis rosettes, rinsed, immersed in infiltration buffer and vacuum-infiltrated for 10 min at 20 kPa.

The composition of infiltration buffer was: KH~2~PO~4~ 50 mM, KCl 0.2 M and PMSF 1 mM, pH 6.2. After infiltration, the leaves were blot-dried, weighed and placed vertically in a 5 ml syringe. The syringes were placed in tubes and centrifuged at 200*g*, 4 °C for 20 min. Apoplastic fluids were collected in eppendorf tubes placed in the bottom of the large tubes. Typically, 30--50 µL of ECWF was retrieved at the end of this procedure.

2.3. Proteome analysis {#s0025}
----------------------

### 2.3.1. Protein sample preparation and in situ digestion {#s0030}

Proteins obtained from ECWF were quantified by bicinchoninic acid spectrophotometric assay; 50 µg of proteins were loaded into a homemade 11% SDS gel and the electrophoretic run was stopped as soon as the protein extracts entered the running gel. The significance of this preliminary step is to remove salts and any other possible interfering compounds from the sample. Bands were then excised and washed several times with 50 mM TEAB (triethylammonium bicarbonate) and dried under vacuum after a short acetonitrile wash. Cysteines were reduced with 10 mM dithiothreitol (in 50 mM TEAB) for 1 h at 56 °C, and alkylated with 55 mM iodoacetamide (in 50 mM TEAB) for 45 min at room temperature in the dark. Gel pieces were then washed with alternate steps of TEAB and acetonitrile, and dried under vacuum. Proteins were *in situ* digested with sequencing grade modified trypsin (Promega, Madison, WI, USA) at 37 °C overnight (12.5 ng/μL trypsin in 50 mM TEAB). Peptides were extracted with three steps of 50% acetonitrile in water. 1 µg of each sample was withdrawn to check digestion efficiency using LC--MS/MS analysis, and the remaining peptide solution was dried under vacuum.

### 2.3.2. iTRAQ labeling and peptide fractionation {#s0035}

Peptides were labeled with iTRAQ reagents (ABSciex) according to the manufacturer׳s instructions. They were labeled with the four iTRAQ tags using a Latin panel strategy: wt UV-B, ggt1 UV-B, wt ctrl and ggt1 ctrl were labeled respectively with 114, 115, 116 and 117 tags in the first replicate; 115, 116, 117, 114 tags in the second and 116, 117, 114, 115 tags in the third replicate. Prior to mixing the samples in a 1:1:1:1 ratio, 1 μg of each sample was analyzed separately to check label efficiency by LC--MS/MS analysis. In these cases, iTRAQ labeling was set as a variable modification in the database search, while the other settings were as reported below ([Section 2.3.5](#s0050){ref-type="sec"}). This step of quality control is particularly useful to highlight possible partial/incomplete labeling that might affect the final quantification outcome. If a relevant number of peptides are identified as being not correctly modified, the labeling step can be potentially repeated. Our control of labeling efficiency showed that all the peptides were correctly identified as being iTRAQ-modified at the N-terminus and at each lysine residue. Only at this point the samples were pooled and dried under vacuum.

### 2.3.3. Strong cation exchange fractionation {#s0040}

To reduce complexity and increase the number of protein and peptide identifications, the samples were subjected to a step of peptide fractionation by strong cation exchange (SCX) chromatography on a SCX cartridge (AB Sciex, MA, USA). The labeled samples were dissolved in 500 µL of buffer A (10 mM KH~2~PO~4~, 25% acetonitrile, pH 3.0) and loaded onto the cartridge using a syringe pump at a flow rate of 50 µL/min. After 3 washes with 500 µL of buffer A, peptides were eluted in a stepwise manner with 500 µL of the following concentrations of KCl in buffer A: 25, 50, 100, 200, and 350 mM. The volume of each fraction was reduced under vacuum to remove acetonitrile. Samples were desalted using C18 cartridges (Sep-Pack, C18, Waters, Milford, MA, USA) according to the manufacturer׳s instructions and dried under vacuum.

### 2.3.4. LC--MS/MS analysis {#s0045}

Samples were suspended in 0.1% formic acid/3% acetonitrile and analyzed by LC--MS/MS. The MS analyses were conducted with a LTQ-Orbitrap XL mass spectrometer (Thermo Fisher Scientific, Pittsburgh, CA, USA) coupled online with a nano-HPLC Ultimate 3000 (Dionex-Thermo Fisher Scientific). Samples were loaded onto a trap-column (300 μm id, 300 A, C18, 3 μm; SGE Analytical Science) at a flow rate of 8 μL/min, washed for 6 min and then transferred to a homemade 10 cm chromatographic column packed in-house into a pico-frit (75 µm id, 10 mm tip, New Objectives) with C18 material (ReproSil, 300 Å, 3 μm).

Peptides were eluted with a linear gradient of acetonitrile/0.1% formic acid from 3% to 50% in 90 min at a flow rate of 250 nL/min. Spray voltage was set at 1.3--1.4 kV, capillary temperature at 200 °C, capillary voltage at 49 V, and tube lens at 120 V. According to the method described by Köcher et al. [@bib6], the instrument performed a full scan at high resolution (60,000) on the Orbitrap, with a mass range of 300--1600 Da, followed by MS/MS scans on the three most intense ions with CID fragmentation on the linear trap. Only for quantification purposes MS/MS scans were performed on the same ions with higher energy collision dissociation (HCD) fragmentation on the Orbitrap (with a resolution of 7500). HCD fragmentation allows to obtain low mass range data suitable for protein quantification. In order to favor the release of reporter ions from the iTRAQ tags and obtain a more reliable quantification, a normalized collision energy of 50 was set for HCD fragmentation. Maximum injection time was set to 100 ms for MS/MS spectra acquired in the linear ion trap, while for full MS and HCD MS/MS spectra was set to 500 ms and 1000 ms respectively. AGC was 5×10^5^ for full MS spectra and 1×10^4^ and 2×10^5^ for CID and HCD spectra respectively. For both CID and HCD fragmentation repeat count was set to 1, while repeat duration and exclusion duration were set to 30 s and 180 s respectively. All ions with charge state +1 or unassigned were excluded by the process of precursor selection. The minimum threshold for triggering the MS/MS acquisition was set to 500 counts. Isolation width was 2 m/z, both for CID and HCD fragmentation methods. For CID, normalized collision energy was set to 35, with activation Q of 0.250 and activation time of 30 ms. As mentioned above, for HCD fragmentation the normalized collision energy was set to 50 to maximize the intensity of the reporter ions. The peptides reliably identified in each sample by the database search (as specified below) were inserted in a static exclusion list that was used to perform (under the same chromatographic and instrumental conditions) a second LC--MS/MS run for each sample fraction. Analyzing the same sample twice with the application of the excluding list allows to increase the number of peptide identifications, as well as the number of protein IDs and sequence coverage. As shown in [Fig. 2](#f0010){ref-type="fig"}, when the same sample is analyzed twice under identical conditions, the very large majority of proteins and peptides are in common between the two analyses (panels A and C, respectively). When the static excluding list is applied during the second analysis, both protein and peptide identifications increase (panels B and D) and, as expected, the effect is much more evident at the peptide level, while for the proteins the improvement is more evident at the level of sequence coverage. By looking more in detail at the results obtained with the application of the excluding list, we could observe that for about 30% of the peptides that are identified as being in common, the MS/MS spectra were acquired from the same peptides in different charge states. Obviously, the application of the static excluding list does not result in a complete lack of overlapping data, but these results clearly show that it is an efficacious method to reduce the undersampling effect in complex samples.

### 2.3.5. Database search and protein quantification {#s0050}

The raw LC--MS/MS files were analyzed using the software Proteome Discoverer 1.4 (Thermo Fisher Scientific), connected to a Mascot Search Engine server (version 2.2.4, Matrix Science, London, UK). The spectra were searched against a ARATH UniProt protein database (version 2014.04.16, 33,353 sequences, 13,619,890 residues, [www.uniprot.org](http://www.uniprot.org){#ir0015} [@bib7]) using a MudPit protocol: all raw files acquired for each biological replicate were processed together, being fractions of the same original sample. Enzyme specificity was set to trypsin with two missed cleavages, and peptide and fragment tolerance was set to 10 ppm and 0.6 Da, respectively. Methylthiocysteine, 4-plex iTRAQ at the N-terminus and Lys were set as fixed modifications, except for the quality control step, where iTRAQ labeling was set as variable modification, as specified above (see [Section 2.3.2](#s0035){ref-type="sec"}). In all cases, Methionine oxidation was selected as variable modification. Percolator in combination with the search against a randomized database was used to assess false discovery rates (FDR). Data were pre-filtered to exclude MS/MS spectra containing less than 5 peaks or with a total ion count below 50. The protein relevance threshold was set to 20 and the peptide cutoff score was set to 10. Only proteins quantified with at least 2 unique peptides of rank 1 and with a 99% confidence (*q* value \<0.01) were considered as positive identifications. Only unique peptides were used for quantification. Quantification data were corrected by normalizing the results on the median value of all measured iTRAQ reporter ratios.

The data deposited in PRIDE database (PXD001807) [@bib2] consist in all raw files acquired for each biological replicate and divided according to the SCX fractionation that was performed for each replicate. The total list of proteins and peptides identified in the study is reported as supplementary material in [@bib1]. The mean value of at least 2 biological replicates was used to express the final quantifications that are reported according to the following ratios: wt (UV-B/ctrl), ggt1 (UV-B/ctrl), ctrl (ggt1/wt) and UV-B (ggt1/wt). A two-tailed *Z* test was performed and only proteins that were quantified with a confidence value of *p*\<0.05 were retained in the final list. The variations were further restricted to proteins exhibiting an expression fold change of at least ±50% (1.5 for upregulated and 0.68 for downregulated proteins).

3. Data {#s0055}
=======

A summary of the main information regarding number of search inputs, PSMs, peptide IDs, and protein IDs is reported in [Table 1](#t0005){ref-type="table"}. As it is possible to observe, for one of the samples only two SCX fractions were obtained. For this sample the amount of apoplastic proteins that were retrieved from the procedure described above ([Section 2.2](#s0020){ref-type="sec"}) was too low to allow a deeper fractionation. The number of protein and peptide IDs from this biological replicate reflect the fact that a lower amount of material was analyzed.

For each of the biological replicates the number of SCX fractions performed, the number of search inputs, PSMs, peptide and protein IDs are reported.

Nevertheless, LC--MS/MS analyses led to the identification of a total of 329 proteins; of them, 208 were found in at least two biological replicates. We restricted our analysis to the 118 proteins that were either apoplastic or unlocalized (based on the Gene Ontology assignment for cellular compartmentalization; 〈[www.uniprot.org](http://www.uniprot.org){#ir0020}〉 [@bib8], accounting for approximately 57% of the total. The choice of including unlocalised proteins may represent a potential risk of considering as apoplastic some proteins that are not; however, we decided to be less conservative since several evidences in literature point to the occurrence of unconventional secreted proteins that are not predicted as such by bioinformatics tools [@bib9], [@bib10]. The variations considered were further restricted to proteins exhibiting an at least ±50% fold change in expression.

Differentially expressed proteins are listed in [Table 2](#t0010){ref-type="table"}, [Table 3](#t0015){ref-type="table"}, [Table 4](#t0020){ref-type="table"}, [Table 5](#t0025){ref-type="table"} and compared in the Venn diagram shown in [Fig. 3](#f0015){ref-type="fig"}. This diagram shows that a subset of proteins are altered both as a consequence of the *ggt1* mutation, and of the UV-B treatment. These proteins are involved in ROS metabolism (as superoxide dismutase At4g25100) and in cell wall remodeling; one is a Leucine-rich repeat-containing protein (At1g33590), which is associated to the plasma membrane and is likely to act as a receptor.

This comparative analysis lead to the hypothesis that the gamma-glutamyl cycle may participate in ROS-mediated environmental stress sensing, by transferring redox signals arising in the apoplast to the inner compartments [@bib1], [@bib4], [@bib11].
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![Experimental workflow. Following apoplastic fluid extraction by the infiltration/centrifugation protocol (see [Section 2](#s0010){ref-type="sec"} for details), electrophoresed proteins were reduced, alkylated and digested with trypsin. Peptides from the four experimental conditions were then labeled with iTRAQ, pooled and analysed by LC--MS--MS for simultaneous quantitation and identification.](gr1){#f0005}

![Effect of the application of the static exclusion list. A strong overlap of data at the protein and peptide level is observed when the same sample is analyzed twice under identical conditions (Panels A and C respectively). When a static exclusion list is generated and included in the instrumental method, the overlap of data is significantly reduced at the protein level (Panel B) and overall at the peptide level (Panel D).](gr2){#f0010}

![Venn diagram showing the apoplastic proteins that are altered (±50% fold change) in the *ggt1* mutant compared to the wildtype (*ggt1*/wt, ctrl), following UV-B treatment in the wildtype (UV-B/ctrl, wt) or in the *ggt1* mutant (UV-B/ctrl, *ggt1*), or in UV-B treated *ggt1 vs* . wildtype mutant plants (*ggt1*/wt, UV-B).](gr3){#f0015}

###### 

Summary of data obtained from LC--MS/MS and database search.

Table 1.

                                     Replicate 1   Replicate 2   Replicate 3
  ---------------------------------- ------------- ------------- -------------
  Number of fractions (.raw files)   10            10            2
  Search inputs                      32,355        37,681        9659
  PSMs                               3746          2602          463
  Peptides                           2020          1572          341
  Proteins                           435           323           84
  Protein groups                     310           241           64
  Unique peptides                    3145          2256          422
  Not unique peptides                262           221           23
  Not quantified peptides            50            11            5
  Redundant peptides                 289           114           13
  CID identifications                3440          2486          448
  HCD identifications                306           116           15

###### 

Expression change values in apoplastic proteins in ggt1 *vs*. wildtype plants under physiological conditions.

Table 2

  **UniProt ID/AC**   **Locus Name**   **ggt1/Col O**   **Description**                                                          **% Cov.**   **\# Pep**
  ------------------- ---------------- ---------------- ------------------------------------------------------------------------ ------------ ------------
  P28493              At1g75040        0.30             Pathogenesis-related protein 5                                           60.7         11
  O24603              At2g43570        0.34             Chitinase class 4-like protein                                           28.5         7
  P33154              At2g14610        0.34             Pathogenesis-related protein 1                                           18.0         3
  Q42589              At2g38540        0.42             Non-specific lipid-transfer protein 1                                    43.2         6
  Q9LEW3              At5g10760        0.44             Aspartyl protease family protein                                         3.5          2
  Q9LMU2              At1g17860        0.48             uncharacterized protein                                                  57.1         11
  F4HR88              At1g33590        0.48             Leucine-rich repeat-containing protein                                   59.3         23
  Q9LRJ9              At3g22060        0.49             Cysteine-rich repeat secretory protein 38                                36.1         10
  Q9LV60              At5g48540        0.50             Cysteine-rich repeat secretory protein 55                                39.2         10
  Q9LXU5              At5g12940        0.51             Leucine-rich repeat-containing protein                                   34.5         12
  P94072              At5g20630        0.52             Germin-like protein subfamily 3 member 3                                 29.4         4
  Q94K76              At5g18470        0.53             Curculin-like (Mannose-binding) lectin family protein                    10.4         4
  Q9LYE7              At5g11420        0.55             uncharacterized protein                                                  34.2         15
  Q9SMU8              At3g49120        0.56             Peroxidase 34                                                            23.5         8
  Q9ZVA2              At1g78830        0.57             Curculin-like (Mannose-binding) lectin-like protein                      42.4         19
  Q94F20              At5g25460        0.58             uncharacterized protein                                                  42.3         17
  Q9FW48              At1g33600        0.58             Leucine-rich repeat-containing protein                                   43.3         19
  Q9M2U7              At3g54400        0.64             Aspartyl protease family protein                                         23.1         11
  Q8W112              At5g20950        0.65             Beta-[D]{.smallcaps}-glucan exohydrolase-like protein                    16.5         11
  Q9ZVS4              At1g03220        0.66             Aspartyl protease-like protein                                           27.7         11
  Q9LT39              At3g20820        0.67             Leucine-rich repeat-containing protein                                   49.9         15
  Q9C5M8              At4g24780        0.68             Probable pectate lyase 18                                                12.3         3
  Q940J8              At4g19410        0.68             Pectinacetylesterase family protein                                      63.2         21
  O23255              At4g13940        1.5              Adenosylhomocysteinase 1                                                 24.74        12
  F4JRV2              At4g25100        1.7              Superoxide dismutase                                                     12.4         3
  F4JBY2              At3g60750        2.2              Transketolase                                                            29.1         17
  O50008              At5g17920        2.4              5-methyltetrahydropteroyltriglutamate\--homocysteine methyltransferase   36.21        28

###### 

Expression change values in apoplastic proteins in UV-B treated *vs*. untreated wildtype plants.

Table 3

  **UniProt ID/AC**   **Locus Name**   **ggt1/Col O**   **Description**                                         **% Cov.**   **\# Pep**
  ------------------- ---------------- ---------------- ------------------------------------------------------- ------------ ------------
  F4HR88              At1g33590        0.55             Leucine-rich repeat-containing protein                  59.3         23
  O81862              At4g19810        0.55             Class V chitinase                                       18.5         5
  Q9LMU2              At1g17860        0.57             uncharacterized protein                                 57.1         11
  F4IAX0              At1g31690        0.57             Putative copper amine oxidase                           7.8          4
  Q9M5J8              At5g06870        0.57             Polygalacturonase inhibitor 2                           20.0         6
  B9DGL8              At5g08370        0.58             Alpha-[D]{.smallcaps}-galactoside galactohydrolase 2    25.7         11
  F4HSQ4              At1g20160        0.61             Subtilisin-like serine endopeptidase-like protein       5.5          3
  F4IIQ3              At2g28470        0.62             Beta-galactosidase                                      11.2         10
  Q9ZVS4              At1g03220        0.65             Aspartyl protease-like protein                          27.7         11
  Q94F20              At5g25460        0.66             uncharacterized protein                                 42.3         17
  Q9FT97              At5g08380        0.68             Alpha-galactosidase 1                                   34.9         13
  Q940J8              At4g19410        0.68             Pectinacetylesterase family protein                     63.2         21
  O65469              At4g23170        1.5              Putative cysteine-rich receptor-like protein kinase 9   14.7         4
  O49006              At3g14310        1.5              Pectinesterase/pectinesterase inhibitor 3               6.9          4
  P24806              At4g30270        1.6              Xyloglucan endotransglucosylase/hydrolase protein 24    24.5         7
  F4J270              At3g57240        1.7              Beta-1,3-glucanase 3                                    51.3         13
  Q9ZV52              At2g18660        1.8              EG45-like domain containing protein 2                   23.9         3
  P46422              At4g02520        1.8              Glutathione S-transferase F2                            59.4         13
  F4JRV2              At4g25100        1.9              Superoxide dismutase                                    12.4         3
  O22126              At2g45470        1.9              Fasciclin-like arabinogalactan protein 8                9.3          4
  P33157              At3g57260        2.1              Glucan endo-1,3-beta-glucosidase, acidic isoform        38.4         11
  F4JBY2              At3g60750        2.7              Transketolase                                           29.1         17
  O80852-2            At2g30860        2.9              Isoform 2 of Glutathione S-transferase F9               24.7         4
  F4HUA0              At1g07930        4.4              Elongation factor 1-alpha                               19.9         8

###### 

Expression change values in apoplastic proteins in UV-B treated *vs*. untreated ggt1 mutant plants.

Table 4

  **UniProt ID/AC**   **Locus Name**   **ggt1/Col O**   **Description**                                                 **% Cov.**   **\# Pep**
  ------------------- ---------------- ---------------- --------------------------------------------------------------- ------------ ------------
  O64757              At2g34930        0.31             Disease resistance-like protein/LRR domain-containing protein   14.6         13
  Q9SG80              At3g10740        0.35             Alpha-[L]{.smallcaps}-arabinofuranosidase 1                     23.6         16
  Q9FZ27              At1g02335        0.37             Germin-like protein subfamily 2 member 2                        20.6         4
  Q9FKU8              At5g44400        0.49             Berberine bridge enzyme                                         11.0         6
  F4K5B9              At5g07030        0.54             Aspartyl protease family protein                                30.8         12
  Q9S7Y7              At1g68560        0.55             Alpha-xylosidase 1                                              13.0         10
  Q9C5C2              At5g25980        0.61             Myrosinase 2                                                    30.0         14
  P33157              At3g57260        0.63             Glucan endo-1,3-beta-glucosidase, acidic isoform                38.4         11

###### 

Expression change values in apoplastic proteins in in ggt1 *vs*. wildtype plants, treated with UV-B radiation.

Table 5

  **UniProt ID/AC**   **Locus Name**   **ggt1/Col O**   **Description**                                       **% Cov**   **\#Pep**
  ------------------- ---------------- ---------------- ----------------------------------------------------- ----------- -----------
  O24603              At2g43570        0.17             Chitinase class 4-like protein                        28.5        7
  P33157              At3g57260        0.26             Glucan endo-1,3-beta-glucosidase, acidic isoform      38.4        11
  Q9SVG4-2            At4g20830        0.43             Isoform 2 of Reticuline oxidase-like protein          40.6        22
  F4J270              At3g57240        0.47             Beta-1,3-glucanase 3                                  51.3        13
  P46422              At4g02520        0.51             Glutathione S-transferase F2                          59.4        13
  O49006              At3g14310        0.55             Pectinesterase/pectinesterase inhibitor 3             6.9         4
  Q9LFA6              At3g52840        0.59             Beta-galactosidase 2                                  10          9
  Q940G5              At4g25900        0.61             Aldose 1-epimerase family protein                     56.0        14
  Q9FKU8              At5g44400        0.68             Berberine bridge enzyme                               11.0        6
  Q9LU14              At3g16370        1.57             GDSL esterase/lipase APG                              34          10
  Q94F20              At5g25460        1.59             uncharacterized protein                               42.3        17
  Q9LFR3              At5g14920        1.80             Gibberellin-regulated protein 14                      14.2        5
  Q39099              At2g06850        1.83             Xyloglucan endotransglucosylase/hydrolase protein 4   49.3        17
  Q940J8              At4g19410        1.88             Pectinacetylesterase family protein                   63.2        21
  O04496              At1g09750        1.92             Aspartyl protease-like protein                        14.0        7
  Q9FH82              At5g45280        2.04             Pectin acetylesterase 11                              34.5        12
  Q9M2U7              At3g54400        2.04             Aspartyl protease family protein                      23.1        11
  Q9ZVA2              At1g78830        2.32             Curculin-like (Mannose-binding) lectin-like protein   42.4        19
  Q9ZVS4              At1g03220        2.50             Aspartyl protease-like protein                        27.7        11
